Literature DB >> 1234503

Immediate effects on human performance of a 1,5-genzodiazepine (clobazam) compared with the 1,4-benzodiazepines, chlordiazepoxide hydrochloride and diazepam.

R G Borland, A N Nicholson.   

Abstract

1 The immediate effects on human performance of the 1,5-benzodiazepine, clobazam (20 mg), and the 1,4-benzodiazepines, chlordiazepoxide hydrochloride (20 mg) and diazepam (10 mg), were studied by adaptive tracking and measurement of reaction time. Each drug was ingested at 09.00 h and performance was measured at 09 h 30 min (0.5 h), 11 h 30 min (2.5 h), 14 h 30 min (5.5 h) and 18 h 30 min (9.5 h after ingestion). 2 With diazepam decrements in performance on adaptive tracking were observed at 0.5 h and 2.5 h and performance was enhanced at 9.5 h after ingestion. With clobazam performance at individual times did not differ significantly from control, but there was evidence of an improvement in performance during the day. There was no evidence of impaired performance on adaptive tracking after chlordiazepoxide hydrochloride. 3 Reaction time was slowed at 0.5 h and 2.5 h after diazepam and chlordiazepoxide hydrochloride. A decrease in reaction time was observed at 9.5 h after diazepam. No changes in reaction time were observed after clobazam. 4 The subjects as a group differentiated correctly between performance decrements on adaptive tracking after diazepam and the absence of performance decrements after clobazam and chlordiazepoxide hydrochloride. The persistence of the decrement in performance after diazepam was accurately assessed. 5 It is evident that the nature and persistence of impaired performance and the ability to appreciate impaired performance vary considerably between the benzodiazepines, and that the choice of a benzodiazepine should include careful consideration of performance sequelae.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1234503      PMCID: PMC1402574          DOI: 10.1111/j.1365-2125.1975.tb01578.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  Plasma levels and derived pharmacokinetic characteristics of unchanged nitrazepam in man.

Authors:  J Rieder
Journal:  Arzneimittelforschung       Date:  1973-02

2.  Effects of diazepam on the EEG in man.

Authors:  J D Montagu
Journal:  Eur J Pharmacol       Date:  1972-01       Impact factor: 4.432

3.  The effects of diazepam or diphenhydramine on healthy human subjects.

Authors:  A Jäättelä; P Männistö; H Paatero; J Tuomisto
Journal:  Psychopharmacologia       Date:  1971

4.  Biological half-life of chlordiazepoxide and its metabolite, demoxepam, in man.

Authors:  M A Schwartz; E Postma; Z Gaut
Journal:  J Pharm Sci       Date:  1971-10       Impact factor: 3.534

5.  Blood level distribution patterns of diazepam and its major metabolite in man.

Authors:  J A De Silva; B A Koechlin; G Bader
Journal:  J Pharm Sci       Date:  1966-07       Impact factor: 3.534

6.  Behavioural sequelae of methaqualone in man and in the monkey (Macaca mulatta).

Authors:  R G Borland; A N Nicholson; C M Wright
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335

7.  Pharmacological and toxicological properties of clobazam (1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-diketo-3H-1,5-benzodiazepine), a new psychotherapeutic agent.

Authors:  F Barzaghi; R Fournex; P Mantegazza
Journal:  Arzneimittelforschung       Date:  1973-05
  7 in total
  38 in total

1.  Proceedings: Effect of diazepam and a soluble salt of diazepam (fosazepam) on sleep in man.

Authors:  C H Clarke; H M Ferres; A N Nicholson; B M Stone
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

2.  Individual and group effects of 10 mg diazepam on drivers' ability, confidence and willingness to act in a gap-judging task.

Authors:  A Wetherell
Journal:  Psychopharmacology (Berl)       Date:  1979-06-21       Impact factor: 4.530

3.  Effect of the 1,5-benzodiazepines, clobazam and triflubazam, on the sleep of man [proceedings].

Authors:  C H Clarke; A N Nicholson; B M Stone
Journal:  Br J Pharmacol       Date:  1976-11       Impact factor: 8.739

Review 4.  GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam.

Authors:  Raman Sankar
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

5.  Effect of diazepam and fosazepam (a soluble derivative of diazepam) on sleep in man.

Authors:  A N Nicholson; B M Stone; C H Clarke
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

6.  [Analytical data of the new 1,5-benzodiazepine clobazam (Frisium) and its main metabolite nor-clobazam (author's transl)].

Authors:  H Schütz
Journal:  Arch Toxicol       Date:  1978-12-28       Impact factor: 5.153

7.  Psychomotor changes during initial day of benzodiazepine medication.

Authors:  J R Wittenborn; C F Flaherty; W E McGough; R J Nash
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

Review 8.  Clobazam: pharmacological and therapeutic profile.

Authors:  G W Hanks
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

9.  Pharmacodynamic interactions of diazepam and intravenous alcohol at pseudo steady state.

Authors:  A L van Steveninck; R Gieschke; H C Schoemaker; M S Pieters; J M Kroon; D D Breimer; A F Cohen
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Nomifensine, clobazam and HOE 8476: effects on aspects of psychomotor performance and cognitive ability.

Authors:  A C Parrott; I Hindmarch; P D Stonier
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.